Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Biomolecules 2012, 2(1), 34-45; doi:10.3390/biom2010034
Review

Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy

* , , , , , , ,  and
Received: 30 November 2011; in revised form: 5 January 2012 / Accepted: 20 January 2012 / Published: 30 January 2012
(This article belongs to the Special Issue Protein SUMOylation)
View Full-Text   |   Download PDF [336 KB, updated 2 February 2012; original version uploaded 30 January 2012]
Abstract: Oligosaccharides, sequences of carbohydrates conjugated to proteins and lipids, are arguably the most abundant and structurally diverse class of molecules. Fucosylation is one of the most important oligosaccharide modifications involved in cancer and inflammation. Recent advances in glycomics have identified several types of glyco-biomarkers containing fucosylation that are linked to certain types of cancer. Fucosylated alpha-fetoprotein (AFP) is widely used in the diagnosis of hepatocellular carcinoma because it is more specific than alpha-fetoprotein. High levels of fucosylated haptoglobin have also been found in sera of patients with various carcinomas. We have recently established a simple lectin-antibody ELISA to measure fucosylated haptoglobin and to investigate its clinical use. Cellular fucosylation is dependent upon fucosyltransferase activity and the level of its donor substrate, guanosine diphosphate (GDP)-fucose. GDP-mannose-4,6-dehydratase (GMDS) is a key enzyme involved in the synthesis of GDP-fucose. Mutations of GMDS found in colon cancer cells induced a malignant phenotype, leading to rapid growth in athymic mice resistant to natural killer cells. This review describes the role of fucosylated haptoglobin as a cancer biomarker, and discusses the possible biological role of fucosylation in cancer development.
Keywords: fucosylation; haptoglobin; TRAIL; cancer; oligosaccharide fucosylation; haptoglobin; TRAIL; cancer; oligosaccharide
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Miyoshi, E.; Moriwaki, K.; Terao, N.; Tan, C.-C.; Terao, M.; Nakagawa, T.; Matsumoto, H.; Shinzaki, S.; Kamada, Y. Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy. Biomolecules 2012, 2, 34-45.

AMA Style

Miyoshi E, Moriwaki K, Terao N, Tan C-C, Terao M, Nakagawa T, Matsumoto H, Shinzaki S, Kamada Y. Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy. Biomolecules. 2012; 2(1):34-45.

Chicago/Turabian Style

Miyoshi, Eiji; Moriwaki, Kenta; Terao, Naoko; Tan, Cheng-Cheng; Terao, Mika; Nakagawa, Tsutomu; Matsumoto, Hitoshi; Shinzaki, Shinichiro; Kamada, Yoshihiro. 2012. "Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy." Biomolecules 2, no. 1: 34-45.



Biomolecules EISSN 2218-273X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert